Effect of low pH treatment on opioid peptides binding to their receptors and functional coupling of G-proteins to adenylyl cyclase in the rat spinal cord

Peptides

Volumn 17, Issue 4, 1996, Pages 625-628

  Reddy, Poluru L ^a   Bhargava, Hemendra N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Adenylate cyclase; Opiate receptors; Rat; Spinal cord

Indexed keywords

ADENYLATE CYCLASE; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETHYLKETAZOCINE; FLUORIDE SODIUM; LEVORPHANOL; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SPINAL CORD;

ANIMALIA;

EID: 0030007631     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00051-4     Document Type: Article

References (17)

1. 1. Bhargava, H. N. Multiple opiate receptors of brain and spinal cord in opiate addiction. Gen. Pharmacol. 22:767-772; 1991.
2. 2. Bhargava, H. N.; Gulati, A.; Ramarao, P. Effect of chonic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord, J. Pharmacol. Exp. Ther. 251:21-26; 1989.
3. s-stimulated adenylate cyclase. J. Neurochem. 50:543-553; 1988.
4. 4. Childers, S. R.; La Riviere, G. Modification of guanine nucleotide regulatory components in brain membranes: II. Relationship of guanosine-5′-triphosphate effects on opiate receptor binding and coupling with adenylyl cyclase. J. Neurosci. 4:2764-2771; 1984.
5. 5. Collier, H. O. J.; Roy, A. C. Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat homogenates. Nature 248:24-27; 1974.
6. 6. Frey, A.; Kebabian, J. W. μ-Opiate receptors, in 7315c tumor tissue mediates inhibition of immunoreactive prolactin release and adenylate cyclase activity. Endocrinology 115:1797-1804; 1984.
7. 7. Gilman, A. G. G proteins and dual control of adenylate cyclase. Cell 36:577-579; 1984.
8. 8. Lambert, S. M.; Childers, S. R. Modification of guanine nucleotide regulatory components in brain membranes: I. Changes in guanine -5′-triphosphate regulation of opiate receptor binding sites. J. Neurosci. 4:2755-2763; 1984.
9. 9. Lowry, O. H.; Rosenbrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
10. 10. Magnan, C.; Paterson, S. J.; Tawani, A.; Kosterlitz, H. W. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn Schmiedebergs Arch. Pharmacol. 319:197-205; 1982.
11. 11. Munson, P. J.; Rodbard, D. LIGAND: A versatile computerized approach for the characterization of ligand systems. Anal. Biochem. 107:220-239; 1980.
12. 12. Nijssen, P. C. G.; Sexton, T.; Childers, S. R. Opioid-inhibited adenylyl cyclase in rat brain membranes: Lack of correlation with high-affinity opioid receptor binding sites. J. Neurochem. 59:2251-2262; 1992.
13. 13. Puttfarcken, P.; Werling, L. L.; Brown, S. R.; Cote, T. E.; Cox, B. M. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at μ- and delta type receptors in 7315c and NG108-15 cells and cell membranes. Mol. Pharmacol. 30:81-89; 1986.
14. 14. Rodbell, M. The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284:17-22; 1980.
15. 15. Selly, D. E.; Breivogel, C. S.; Childers, S. R. Modification of G protein-coupled functions by low pH pretreatment of membranes from NG108-15 cells: Increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol. Pharmacol. 44:731-741; 1993.
16. 16. Sharma, S. K.; Nirenberg, M.; Klee, W. Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA 72:590-594; 1975.
17. 17. Yu, V. C.; Richards, M. L.; Sadee, W. A human neuroblastoma cell line expresses mu and delta opioid receptor sites. J. Biol. Chem. 261:1065-1070; 1986.